EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Marek Svoboda, Queenie K.-G. Tan, Chung Lee

Genetics in Medicine Open · 2026 · 4 · 104493

DOI: 10.1016/j.gimo.2026.104493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics in Medicine Open, 2026. Verfasst von Marek Svoboda und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Svoboda, M., Tan, Q. K., & Lee, C. (2026). Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open, 4, 104493. https://doi.org/10.1016/j.gimo.2026.104493

Vancouver

Svoboda M, Tan QK, Lee C. Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. 2026;4:104493. doi:10.1016/j.gimo.2026.104493

BibTeX
@article{Svoboda2026,
  author = {Svoboda, Marek and Tan, Queenie K.-G. and Lee, Chung},
  title = {Ctexli (chenodiol) approved for treatment of cerebrotendinous xanthomatosis (CTX) in adults: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)},
  journal = {Genetics in Medicine Open},
  year = {2026},
  volume = {4},
  pages = {104493},
  doi = {10.1016/j.gimo.2026.104493}
}
Kostenlos starten →